Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Lancet. Oncology|January 5, 2025
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategiesTriparna Sen, Yosuke Dotsu, Virginia Corbett, et al.
Journal of Thoracic Disease|July 10, 2019
Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancerJunji Koyama, Atsushi Horiike, Takahiro Yoshizawa, et al.
Cancer Science|July 31, 2019
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patientsSatoru Kitazono, Kazuko Sakai, Noriko Yanagitani, et al.
Frontiers in Oncology|December 25, 2025
Acute amivantamab-induced myocardial injury in a patient with epidermal growth factor receptor-mutant lung cancer: a first case reportSeiya Kaneko, Yosuke Dotsu, Tomoaki Inoue, et al.
Thoracic Cancer|August 17, 2022
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastasesRyosuke Ogata, Hiroshi Soda, Hiroaki Senju, et al.
Thoracic Cancer|May 29, 2020
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II studyTakaya Ikeda, Shinnosuke Takemoto, Hiroaki Senju, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Trends in Outpatient Chemotherapy for Thoracic Oncology]Minoru Fukuda, Hiroyuki Yamaguchi, Shinnosuke Takemoto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancerRyo Ariyasu, Shingo Nishikawa, Ken Uchibori, et al.
Thoracic Cancer|November 20, 2020
Dabrafenib and trametinib therapy in an elderly patient with non-small cell lung cancer harboring the BRAF V600E mutationYosuke Dotsu, Minoru Fukuda, Noritaka Honda, et al.
Current Oncology (Toronto, Ont.)|April 27, 2026
Regression of a Non-Irradiated Lung Adenocarcinoma During Glioblastoma-Directed Chemoradiotherapy: A Case ReportMizuki Iwanaga, Yosuke Dotsu, Takeshi Hiu, et al.
Pageof 4